Louis Chen
Stock Analyst at Cantor Fitzgerald
(n/a)
# 4,913
Out of 4,914 analysts
11
Total ratings
9.09%
Success rate
-55.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $4.12 | - | 8 | Sep 10, 2024 | |
| THTX Theratechnologies | Reiterates: Overweight | $36 | $3.16 | +1,039.24% | 2 | Jul 13, 2023 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $35.87 | +53.33% | 1 | Feb 24, 2022 |
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $4.12
Upside: -
Theratechnologies
Jul 13, 2023
Reiterates: Overweight
Price Target: $36
Current: $3.16
Upside: +1,039.24%
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $35.87
Upside: +53.33%